Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 17/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 10/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 10/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.67 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.67 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | CYP3A43 | Q9HB55 | 1/20 | 0.67 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.67 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.62 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.62 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.62 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.57 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Genaconazole SCHEMBL9774648 | 1.00 | CYP3A4 (0.67) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| Genaconazole SCHEMBL30011920 | 1.00 | CYP3A4 (0.67) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| Genaconazole SCHEMBL1455652 | 1.00 | CYP3A4 (0.67) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| Genaconazole SCHEMBL8937907 | 1.00 | CYP3A4 (0.67) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL31512306 | 0.91 | CYP3A4 (0.56) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL9119825 | 0.90 | CYP3A4 (0.66) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL9044739 | 0.89 | CYP3A4 (0.64) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL9044551 | 0.89 | CYP3A4 (0.64) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL9044565 | 0.89 | CYP3A4 (0.64) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL9118073 | 0.89 | CYP3A4 (0.63) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637708-A2 | SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING HYOSCYAMINE | Novaliq GmbH (DE) | 2025-10-29 | — | — | EP | claimed |
| WO-2024133913-A9 | SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING HYOSCYAMINE | NOVALIQ GMBH (DE) | 2025-03-20 | — | — | WO | claimed |
| WO-2024133913-A2 | SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING HYOSCYAMINE | NOVALIQ GMBH (DE) | 2024-06-27 | — | — | WO | claimed |
| US-4988722-A | Fungicide solutions for injections | SCHERING CORPORATION (US) | 1991-01-29 | — | — | US | claimed |
| EP-2841109-B1 | PRODRUGS OF HYDROXYL-COMPRISING DRUGS | ASCENDIS PHARMA AS (DK) | 2026-04-15 | — | — | EP | disclosed |
| EP-4637708-A2 | SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING HYOSCYAMINE | Novaliq GmbH (DE) | 2025-10-29 | — | — | EP | disclosed |
| US-12370352-B2 | Nasal and ophthalmic delivery of aqueous corticosteroid solutions | CYDEX PHARMACEUTICALS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| CN-119980482-A | Method for preparing On-DNA sulfinic acid structural compound and application thereof | 康龙化成(宁波)科技发展有限公司 | 2025-05-13 | — | — | CN | disclosed |
| WO-2024133913-A9 | SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING HYOSCYAMINE | NOVALIQ GMBH (DE) | 2025-03-20 | — | — | WO | disclosed |
| US-20250032457-A1 | METHODS OF TREATING ANDROGENIC ALOPECIA AND/OR SKIN CONDITIONS | RAUCH ERIC (US) | 2025-01-30 | — | — | US | disclosed |
| CN-118257005-B | On-DNA beta-hydroxy sulfone structural compound, synthetic method and application thereof | 康龙化成(宁波)科技发展有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-118257005-A | On-DNA beta-hydroxy sulfone structural compound, synthetic method and application thereof | 康龙化成(宁波)科技发展有限公司 | 2024-06-28 | — | — | CN | disclosed |
| US-11786599-B2 | Releasable conjugates | QUIAPEG PHARMACEUTICALS AB (SE) | 2023-10-17 | — | — | US | disclosed |
| US-20220339414-A1 | NASAL AND OPHTHALMIC DELIVERY OF AQUEOUS CORTICOSTEROID SOLUTIONS | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2022-10-27 | — | — | US | disclosed |
| CN-114787200-A | Method for forming inclusion complex using hydrophilic beta-cyclodextrin derivatives and compositions thereof | 塔卡美国公司 | 2022-07-22 | — | — | CN | disclosed |
| EP-4011396-A1 | RELEASABLE CONJUGATES | QuiaPEG Pharmaceuticals AB (SE) | 2022-06-15 | — | — | EP | disclosed |
| WO-2022060744-A1 | METHODS OF TREATING ANDROGENIC ALOPECIA AND/OR SKIN CONDITIONS | RAUCH ERIC (US) | 2022-03-24 | — | — | WO | disclosed |
| US-5545558-A | SELECTIVE HYDROLYSIS OF THE COORESPONDING OXYKETONE | SCHERING CORPORATION (US) | 1996-08-13 | — | — | US | disclosed |
| EP-0537921-A2 | Enzymatic synthesis of chiral alpha-hydroxyketones and derivatives | SCHERING CORPORATION (US) | 1993-04-21 | — | — | EP | disclosed |
| WO-1993007289-A1 | ENZYMATIC SYNTHESIS OF CHIRAL α-HYDROXYKETONES AND DERIVATIVES | SCHERING CORPORATION (US) | 1993-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12370352-B2 | Nasal and ophthalmic delivery of aqueous corticosteroid solutions | CRH, HRH1, IL5 | CYP3A4 2163/4885CYP2C9 2205/4885CYP2C19 1048/4885 |
| US-11786599-B2 | Releasable conjugates | GUSB, ABCB11, UGT2B7 | CYP3A4 209/4885CYP2C9 131/4885CYP2C19 120/4885 |
| US-20220339414-A1 | NASAL AND OPHTHALMIC DELIVERY OF AQUEOUS CORTICOSTEROID SOLUTIONS | CRH, HRH1, IL5 | CYP3A4 2163/4885CYP2C9 2205/4885CYP2C19 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.